top of page
Home
Team
Portfolio
Community
Investor Portal
More...
Use tab to navigate through the menu items.
2016
2022
2021
2020
2019
2018
2017
2016
2015
Solas BioVentures to Seek Up to $100M for Second Early-Stage Fund
SEPT 2, 2016
Learn More
Drug Developer Arrivo BioVentures Launches With $49M
MAY 25, 2016
Learn More
CardioNXT Secures Additional $1.5M Funding From Solas BioVentures To Drive Atrial Fibrillation Treatment Innovation
MAY 24, 2016
Learn More
bottom of page
